[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-435641-105":59,"doc-detail-435641-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","corrigendum-pharmacological-inhibition-of-macrophage-toll-like-receptor-4nuclear-factor-kappa-b-alleviates-rhabdomyolysis-induced-acute-kidney-injury","Corrigendum - Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury","","This document presents a formal corrigendum for the research article titled \"Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury,\" originally published in the Chinese Medical Journal. The authors acknowledge an error involving the misplacement of images during the figure organization process. The provided content includes the updated and corrected Figure 4, which visually demonstrates the experimental findings regarding F4/80-positive cells per high-power field (HPF) under various treatment conditions, including control, glycerol, and pharmacological interventions (Gly+CLI-095 and Gly+P814C). The authors clarify that this correction does not alter the study's overall results or scientific conclusions and offer an apology for the inconvenience.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/corrigendum-pharmacological-inhibition-of-macrophage-toll-like-receptor-4nuclear-factor-kappa-b-alleviates-rhabdomyolysis-induced-acute-kidney-injury/435641/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/corrigendum-pharmacological-inhibition-of-macrophage-toll-like-receptor-4nuclear-factor-kappa-b-alleviates-rhabdomyolysis-induced-acute-kidney-injury/435641.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-09-30","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was this corrigendum published?","Question",{"text":112,"@type":113},"The authors discovered that images in their original article, 'Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury', were misplaced during figure preparation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Does this correction change the study's findings?",{"text":117,"@type":113},"No, the authors state that the error in figure placement does not affect the results or the conclusions of the original research article.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the updated Figure 4 show?",{"text":121,"@type":113},"The updated figure shows the number of F4/80-positive cells per high-power field (HPF) in different groups, illustrating the impact of treatments on macrophage infiltration following rhabdomyolysis-induced acute kidney injury.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},435641,1790779782,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":8,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":81},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Corrigendum  \nCorrigendum: Survivin (BIRC5) regulates bladder fibrosis in a rat model of partial bladder outlet obstruction  \nThe authors declare that in the article published in Volume 136, Issue 1, of the Chinese Medical Journal,[1] an error was identified in the fifth paragraph, where “Then, we selected the top 20 hub genes ranked by the Matthews correlation coefficient (MCC) method via CytoHubba plug-in in Cytoscape.” should be corrected to “Then, we selected the top 20 hub genes ranked by the Maximal Clique Centrality (MCC) method via CytoHubba plug-in in Cytoscape.” This error does not affect the results and  \nconclusions of the article. The authors deeply apologize for any inconvenience caused.  \nReference  \n1. Di X, Jin X, Xiang L, Gao X, Peng L, Wang W, et al. Survivin (BIRC5) regulates bladder fibrosis in a rat model of partial bladder outlet obstruction. Chin Med J 2023;136:117–119 . doi: 10.1097/ CM9 .0000000000002022.  \nCorrigendum: Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysisinduced Acute Kidney Injury  \nIn the article “Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury” published in Vol. 130, Issue 18, pages 2163–2169 of the Chinese Medical Journal,[1] the authors admit that they misplaced the pictures in the procedure of organizing the figure. The error does not affect the results and conclusions of the article. The updated and correct Figure 4 is shown below.  \nThe authors deeply apologize for any inconvenience caused.  \nReference  \n1. Huang RS, Zhou JJ, Feng YY, Shi M, Guo F, Gou SJ, et al. Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factorkappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury. Chin MedJ 2017;130:2163–2169. doi: 10.4103/0366-6999.213406.","cbCaiazz8OUwvd9H","https://ap.wps.com/l/cbCaiazz8OUwvd9H","pdf",530137,"English","# Corrigendum Overview\n## Survivin (BIRC5) Correction\n## Pharmacological Inhibition of Macrophage TLR4 Correction\n### Corrected Figure 4 Presentation","[{\"question\":\"Why was this corrigendum published?\",\"answer\":\"The authors discovered that images in their original article, 'Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury', were misplaced during figure preparation.\"},{\"question\":\"Does this correction change the study's findings?\",\"answer\":\"No, the authors state that the error in figure placement does not affect the results or the conclusions of the original research article.\"},{\"question\":\"What does the updated Figure 4 show?\",\"answer\":\"The updated figure shows the number of F4/80-positive cells per high-power field (HPF) in different groups, illustrating the impact of treatments on macrophage infiltration following rhabdomyolysis-induced acute kidney injury.\"}]","Corrigendum - Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury | PDF",1790674497]